All individual trials at National Cancer Institute (NCI)

An AllTrials project

All individual trials at National Cancer Institute (NCI)

377 out of 382

98.7%

$498,022,312

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	National Cancer Institute (NCI)	NCT03206047	A Randomized Phase 2 Trial of Atezolizumab (MPDL3280A), SGI-110 and CDX-1401 Vaccine in Recurrent Ovarian Cancer	2020-11-10	1254
overdue	National Cancer Institute (NCI)	NCT03517969	A Phase 2 Study of M6620 (VX-970, Berzosertib) in Combination With Carboplatin Compared With Docetaxel in Combination With Carboplatin in Metastatic Castration-Resistant Prostate Cancer	2021-08-10	981
overdue	National Cancer Institute (NCI)	NCT03872427	A Phase II Basket Trial of Glutaminase Inhibitor (BEGIN) Telaglenastat (CB-839) HCL in Patients With NF1 Aberrations, NF1 Mutant Malignant Peripheral Nerve Sheath Tumors (MPNST), KEAP1/NRF2 and LKB1 Aberrant Tumors	2023-10-30	169
overdue	National Cancer Institute (NCI)	NCT00217737	A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers [pACT]	2024-02-22	54
overdue	National Cancer Institute (NCI)	NCT03036930	Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial	2024-03-04	44

Download this data